Neurocrine Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 814.5M | 805.5M | 794.9M | 687.5M | 572.6M | 627.7M | 622.1M | 590.2M |
| Cost of Goods Sold | 13.8M | 17.6M | 14.0M | 11.3M | 9.2M | 9.3M | 8.0M | 9.2M |
| Gross Profit | 800.7M | 787.9M | 780.9M | 676.2M | 563.4M | 618.4M | 614.1M | 581.0M |
| R&D Expenses | 296.2M | 258.2M | 250.0M | 244.3M | 263.2M | 185.6M | 195.0M | 191.1M |
| Operating Expenses | 614.7M | 577.0M | 541.9M | 530.6M | 539.8M | 476.4M | 430.3M | 435.6M |
| Operating Income | 186.0M | 210.9M | 239.0M | 145.6M | 23.6M | 142.0M | 183.8M | 145.4M |
| Other Income / Gains | 60.8M | 28.5M | 52.8M | 13.9M | -8.9M | 20.6M | 6.5M | -46.8M |
| Net Income | 197.9M | 153.7M | 209.5M | 107.5M | 7.9M | 103.1M | 129.8M | 65.0M |
| EPS (Diluted) | 1.97 | 1.54 | 2.11 | 1.09 | 0.08 | 1.03 | 1.28 | 0.64 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.983 | 0.978 | 0.982 | 0.984 | 0.984 | 0.985 | 0.987 | 0.984 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 318.5M | 301.8M | 291.6M | 286.3M | 276.5M | 287.8M | 234.3M | 242.0M |
| Other Expenses | 0 | 17.0M | 300K | 0 | 100K | 3.0M | 1.0M | 2.5M |
| Cost And Expenses | 628.5M | 594.6M | 555.9M | 541.9M | 549.0M | 485.7M | 438.3M | 444.8M |
| Interest Income | 28.1M | -42.8M | 22.2M | 20.6M | 21.7M | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.7M |
| Depreciation And Amortization | 7.3M | 7.5M | 7.7M | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M |
| Ebitda | 254.1M | 235.4M | 299.5M | 166.8M | 31.3M | 181.7M | 191.3M | 155.2M |
| Ebitdaratio | 0.312 | 0.292 | 0.377 | 0.243 | 0.055 | 0.289 | 0.308 | 0.263 |
| Operating Income Ratio | 0.228 | 0.262 | 0.301 | 0.212 | 0.041 | 0.226 | 0.295 | 0.246 |
| Income Before Tax | 246.8M | 239.4M | 291.8M | 159.5M | 14.7M | 162.6M | 190.3M | 98.6M |
| Income Before Tax Ratio | 0.303 | 0.297 | 0.367 | 0.232 | 0.026 | 0.259 | 0.306 | 0.167 |
| Income Tax Expense | 48.9M | 85.7M | 82.3M | 52.0M | 6.8M | 59.5M | 60.5M | 33.6M |
| Net Income Ratio | 0.243 | 0.191 | 0.264 | 0.156 | 0.014 | 0.164 | 0.209 | 0.11 |
| Epsdiluted | 1.91 | 1.48 | 2.04 | 1.06 | 0.08 | 1.00 | 1.24 | 0.63 |
| Weighted Average Shs Out | 100.5M | 99.5M | 99.4M | 99.0M | 99.7M | 100.0M | 101.1M | 100.8M |
| Weighted Average Shs Out Dil | 103.4M | 102.5M | 102.5M | 101.0M | 102.5M | 102.9M | 104.3M | 103.9M |